Vacc-4x + Lenalidomide vs. Vacc-4x +Placebo in HIV-1-infected Subjects on Antiretroviral Therapy (ART)

Clinical trial NCT01704781 · COMPLETED

Trial details

NCT number: NCT01704781
Sponsor: Bionor Immuno AS
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

HIV-1 Infection

Start date: 2012-09-01
Primary completion: 2014-08-01
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.